Australian Health Authorities Issue Warnings Over Rising Use of Unapproved Peptides

Health authorities in Australia and across the globe are issuing warnings regarding the increasing use of unapproved peptides, which are frequently marketed for muscle growth, weight loss, and anti-aging. While some peptides have legitimate medical uses, many products currently sold online bypass regulatory safety standards and clinical trials. Experts highlight significant health risks, including potential organ damage and contamination from unregulated manufacturing processes. The rise of “biohacking” and social media promotion has driven demand for these substances, despite the lack of data on their long-term safety and efficacy.

• Peptides are short chains of amino acids that can influence various biological processes, but many versions are being sold without pharmaceutical oversight.
• Regulatory bodies, including the Therapeutic Goods Administration (TGA) in Australia, have raised concerns about the distribution of these substances through unregulated online channels.
• Commonly sought-after effects include enhanced athletic performance, skin tanning, and accelerated fat loss.
• Health risks associated with unapproved peptides include kidney and liver toxicity, cardiovascular issues, and an increased risk of developing certain cancers.
• Products manufactured in unregulated facilities often carry a high risk of bacterial contamination or chemical impurities.
• Medical professionals warn that self-administering these substances can lead to severe hormonal imbalances and unknown long-term health complications.

Based in Singapore, CNA (Channel News Asia) covers global developments with an Asian perspective, with correspondents based in major cities across Asia, including Kuala Lumpur, Jakarta, Bangkok, Tokyo, Seoul and Beijing, as well as in New York, Washington D.C. and London.

Official website: https://www.channelnewsasia.com/

Original video here.

This summary has been generated by AI.